This research project tries to improve our knowledge of the immune response in melanoma and aims to develop new treatments that are effective but minimise damage to the healthy parts of the body.  Melanoma is a type of skin cancer derived from pigmented skin cells (melanocytes), and is one of the fastest growing cancers in the UK. While melanoma can be treated effectively with surgery, chemotherapy and radiotherapy in the early stages, it can cause significant side effects for the patients.  Currently, there is no cure available in advanced stages.

Study involvement includes the donation of blood (1-6 tablespoons), and/or the donation of skin tissue that is removed as part of a planned surgery or collected via a skin biopsy, and/or donating a sample of fluid from an induced blister. 

Adults with melanoma, as well as adults without any history of cancer can take part.

For more information, please contact SkinHealth@kcl.ac.uk